// App-Quantinova.ai

: Impact of a Standardized Hydroxyurea Dose Regimen for Extreme Thrombocytosis in Children after Pancreatectomy with Islet Autotransplantation

Researchers

Presenter

  • Alexander A Boucher

Principal Investigators

  • Todd M. Jenkins

  • Lori Luchtman-Jones

  • Joseph S. Palumbo

  • Tom K Lin

  • Maisam Abu-El-Haija

  • Jaimie D Nathan

Medical Centers

  • Cancer and Blood Diseases Institute, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH

  • Cancer and Blood Diseases Institute, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Division of Hematology, Cancer and Blood Diseases Institute, Children's Hospital Med. Ctr., Cincinnati, OH

  • Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Gastroenterology (GU)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Extreme thrombocytosis

  • Hereditary pancreatitis

  • Pancreatitis

  • Neutropenia

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Mean corpuscular volume

  • Thrombocytosis

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

  • Enoxaparin

  • Enoxaparin sodium

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved